In vivo and ex vivo assessment of the interaction between ivermectin and danofloxacin in sheep

Veterinary Journal

Volumn 192, Issue 3, 2012, Pages 422-427

  Ballent, Mariana ^a,b   Lifschitz, Adrián ^a,b   Virkel, Guillermo ^a,b   Sallovitz, Juan ^a   Maté, Laura ^a,b   Lanusse, Carlos ^a,b  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b Consejo Nacional de Investigaciones Científicas y Técnicas ^*  (Argentina)

Author keywords

Danofloxacin; Intestinal transport; Ivermectin; P glycoprotein; Pharmacokinetics; Sheep

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; DANOFLOXACIN; IVERMECTIN; PANTOPRAZOLE; RHODAMINE 123;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; DRUG TRANSPORT; EX VIVO STUDY; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INTESTINE ABSORPTION; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PROTEIN FUNCTION; SHEEP; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTHELMINTICS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DRUG INTERACTIONS; FLUOROQUINOLONES; INTESTINES; IVERMECTIN; MALE; RATS; SHEEP;

ANIMALIA; OVIS ARIES; RATTUS;

EID: 84861867171     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2011.09.006     Document Type: Article

References (29)

1. Aliabadi F.S., Landoni M.F., Lees P. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy 2003, 47:626-635.
2. Alvinerie M., Sutra J.F., Galtier P. Ivermectin in goat milk after subcutaneous injection. Veterinary Research 1993, 24:417-421.
3. Ballent M., Lifschitz A., Virkel G., Sallovitz J., Lanusse C. Modulation of the p-glycoprotein-mediated intestinal secretion of ivermectin: In vitro and in vivo assessments. Drug Metabolism and Disposition 2006, 34:457-463.
4. Ballent M., Lifschitz A., Virkel G., Sallovitz J.M., Lanusse C. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: Itraconazole-mediated changes on gastrointestinal disposition. Journal of Veterinary Pharmacology and Therapeutics 2007, 30:242-248.
5. De Montigny P., Shim J.S., Pivnichny J.V. Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent. Journal of Pharmaceutical and Biomedical Analysis 1990, 8:507-511.
6. Escudero E., Cárceles C.M., Fernandez-Varon E., Marin P., Benchaoui H. Pharmacokinetics of danofloxacin 18% in lactating sheep and goats. Journal of Veterinary Pharmacology and Therapeutics 2007, 30:572-577.
7. Fuhr U. What is the true risk of a pharmacokinetic drug-drug interaction?. European Journal of Clinical Pharmacology 2007, 63:897-899.
8. Gibaldi M., Perrier D. Pharmacokinetics 1982, Marcel Dekker Inc., New York, USA. Second Ed. Revised and Expanded.
9. González C., Moreno L., Small J., Jones D.G., Sánchez Bruni S.F. A liquid chromatographic method, with fluorometric detection, for the determination of enrofloxacin and ciprofloxacin in plasma and endometrial tissue of mares. Analytica Chimica Acta 2006, 560:227-234.
10. Griffiths N.M., Hirst B.H., Simmons N.L. Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers. British Journal of Pharmacology 1993, 108:575-576.
11. Jani M., Makai I., Kis E., Szabó P., Nagy T., Krajcsi P., Lespine A. Ivermectin interacts with human ABCG2. Journal of Pharmaceutical Sciences 2011, 100:94-97.
12. Laffont C.M., Toutain P., Alviniere M., Bousquet-Mélou A. Intestinal secretion is a major route for parent ivermectin elimination in the rat. Drug Metabolism and Disposition 2002, 30:626-630.
13. Lenernnäs H. Human jejunal effective permeability and its correlation with preclinical drug absorption models. Journal of Pharmacy and Pharmacology 1997, 49:627-638.
14. Lespine A., Lespine A., Dupuy J., Orlowski S., Nagy T., Glavinas H., Krajcsi P., Alvinerie M. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chemical and Biological Interactions 2006, 159:169-179.
15. Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., Alvinerie M. Interactions of macrocyclic lactones with P-glycoprotein: Structure-affinity relationship. European Journal of Pharmaceutical Sciences 2007, 30:84-94.
16. Lifschitz A., Virkel G., Imperiale F., Sutra J.F., Galtier P., Lanusse C., Alvinerie M. Moxidectin in cattle: Correlation between plasma and target tissues disposition kinetics. Journal of Veterinary Pharmacology and Therapeutics 1999, 22:266-273.
17. Lifschitz A., Virkel G., Sallovitz J., Sutra J.F., Galtier P., Alvinerie M., Lanusse C. Comparative distribution of ivermectin and doramectin to tissues of parasitic location in cattle. Veterinary Parasitology 2000, 87:327-338.
18. Lifschitz A., Virkel G., Sallovitz J., Imperiale F., Pis A., Lanusse C. Loperamide modifies the tissue disposition kinetics of ivermectin in rats. Journal of Pharmacy and Pharmacology 2004, 56:61-67.
19. Lifschitz A., Suarez V.H., Sallovitz J., Cristel S.L., Imperiale F., Ahoussou S., Schiavi C., Lanusse C. Cattle nematodes resistant to macrocyclic lactones: Comparative effects of P-glycoprotein modulation on the efficacy and disposition kinetics of ivermectin and moxidectin. Experimental Parasitology 2010, 125:172-178.
20. Lifschitz A., Entrocasso C., Alvarez L., Lloberas M., Ballent M., Manazza G., Virkel G., Borda B., Lanusse C. Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep. Veterinary Parasitology 2010, 172:291-298.
21. Lowes S., Simmons N.L. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells. British Journal of Pharmacology 2002, 135:1267-1275.
22. McKellar Q.A., Gibson I.F., McCormack R.Z. Pharmacokinetics and tissue disposition of danofloxacin in sheep. Biopharmaceutics and Drug Disposition 1998, 19:23-129.
23. Moreno L., Ceballos L., Lifschitz A., Bistoletti M., Alvarez L., Lanusse C. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: Age/body weight related changes to the kinetic disposition of both compounds. Research Veterinary Science 2010, 88:315-320.
24. Muenster U., Grieshop B., Ickenroth K., Gnoth M.J. Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions. Pharmacology Research 2008, 25:2320-2326.
25. Pérez R., Palma C., Núñez M.J., Cox J., Arboix M. Pharmacokinetics of ivermectin in pregnant and nonpregnant sheep. Journal of Veterinary Pharmacology and Therapeutics 2008, 31:71-76.
26. Real R., Egido E., Pérez M., González-Lobato L., Barrera B., Prieto J.G., Alvarez A.I., Merino G. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: Interaction with ivermectin. Journal of Veterinary Pharmacology and Therapeutics 2011, 34:313-321.
27. Schinkel A.H., Wagenaar E., van Deemter L., Mol C., Borst P. Absence of the mdr-1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. Journal of Clinical Investigation 1995, 96:1698-1705.
28. Schrickx J., Fink-Gremmels J. P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model. Journal of Veterinary Pharmacology and Therapeutics 2007, 30:25-31.
29. Stephens R.H., O'Neill C.A., Warhurst A., Carlson G.L., Rowland M., Warhurst G. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. Journal of Veterinary Pharmacology and Therapeutics 2001, 296:584-591.